Register for this Live Webinar
Plasmid DNA sits at the core of every cell and gene therapy, yet today’s supply chain remains slow, constrained, and built on outdated technologies. At Bionova Scientific & Syenex, we’re changing that.
We’ve developed a next-generation, insertional-element–free plasmid DNA platform engineered for speed, quality, and scalable manufacturing-designed to eliminate today’s bottlenecks and meet the needs of tomorrow’s genetic medicines.
In this webinar, we’ll highlight a case study featuring Vivo Cell, the first open-access in vivo T-cell engineering platform developed by Syenex. When Bionova supplies high-quality GMP plasmids, manufacturing moves beyond solving supply-chain pain points, it becomes the foundation enabling a new class of genetic medicines that bridges ex vivo and in vivo modalities. Together, this opens a path to therapies that were previously out of reach.
Offered Free by: Bionova Scientific
See All Resources from: Bionova Scientific
